高级检索
当前位置: 首页 > 详情页

miR-214-3p inhibits LPS-induced macrophage inflammation and attenuates the progression of dry eye syndrome by regulating ferroptosis in cells

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]YanAn Hosp Kunming City, Dept Ophthalmol, Kunming 650051, Yunnan, Peoples R China [2]Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Dept Informat, Affiliated Hosp, Kunming 650032, Yunnan, Peoples R China [3]Kunming Med Univ, Dept Ophthalmol, Kunming 650500, Yunnan, Peoples R China
出处:
ISSN:

关键词: Dry eye syndrome miR-214-3p Macrophages Inflammation Ferroptosis TFRC

摘要:
BackgroundDry eye disease (DED) is an ocular illness caused by insufficient tear secretion or poor tear quality, and inflammation is a key factor in its pathogenesis. Previous studies have shown that miRNAs are important regulatory factors in DED.ObjectiveThe purpose of this study was to explore the potential mechanism by which miR-214-3p influenced the DED process by regulating the macrophage inflammatory response.MethodsWe induced THP-1 cells to differentiate into M0 macrophages with 100 ng/mL phorbol-12-myristate-13-acetate (PMA) and then added 15 ng/mL lipopolysaccharide (LPS) to induce inflammation. The expression of related genes and proteins was detected via RT-qPCR, Western blotting, ELISA and immunofluorescence staining; cell viability was measured using the CCK-8 assay; and flow cytometry was used to detect ROS levels.ResultsIn tear and serum samples from DED patients, the levels of miR-214-3p, IL-10, and Arg1 were decreased, and the levels of IL-6, TNF-alpha, IL-1 beta, and iNOS expression were increased. Moreover, the overexpression of miR-214-3p attenuated the effect of LPS and inhibited M1 polarization and inflammation in macrophages. Mechanistically, miR-214-3p inhibited macrophage ferroptosis by downregulating TFRC expression, thereby inhibiting macrophage M1 polarization and inflammation and alleviating the progression of DED.ConclusionsOur study indicated that the upregulation of miR-214-3p expression might be a new target for DED therapy.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
最新[2023]版:
大类 | 4 区 生物学
小类 | 4 区 生化与分子生物学 4 区 生物工程与应用微生物 4 区 遗传学
JCR分区:
出版当年[2023]版:
Q3 GENETICS & HEREDITY Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Q4 GENETICS & HEREDITY
最新[2023]版:
Q3 GENETICS & HEREDITY Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Q4 GENETICS & HEREDITY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]YanAn Hosp Kunming City, Dept Ophthalmol, Kunming 650051, Yunnan, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82182 今日访问量:0 总访问量:679 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号